# CoWin Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cowin-biosciences

- Industry: Biotechnology
- Headquarters: Taizhou, China
- Website: www.cwbiotech.com
- Latest round: Series A (Dec 1, 2009)
- Investors on record: 1

## About

Established in 2007 and based in Beijing, China, CoWin Biosciences is a biotechnology company that provides biology reagents in life science research, genetic testing, and in the vitro diagnostics (IVD). It has 23 molecule testing technologies, and automated equipment for polymerase chain reaction (PCR), and nucleic acid extraction. Moreover, CoWin Biosciences has two subsidiaries in Beijing, and US, and 8 additional offices, such as Shanghai, Shenzhen, and Chengdu. In 2022, it was listed on Shanghai Sci-Tech Innovational Board under the number 688426.

CoWin Biosciences provides molecule testing products, including raw material enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents, and molecular diagnostic kits. Its 54 products received domestic medical device registration certificates, and 16 products received FDA  and CE medical device registration certifications. It also provides molecule testing services, including new coronavirus nucleic acid test services, H. pylori test services, and colorectal cancer screening technology services.

## Funding rounds

- Series A, Dec 1, 2009 — Leaguer Group

## Investors

- Leaguer Group (https://capitalatlas.ai/funds/leaguer-group) — Series A